Novavax Inc NVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:13 PM EST
17.02quote price arrow down-0.20 (-1.16%)
Volume
31,997
Close
17.22quote price arrow up+0.44 (+2.62%)
Volume
3,183,974
52 week range
15.53 - 236.50
Loading...
  • Open16.78
  • Day High17.79
  • Day Low16.74
  • Prev Close16.78
  • 52 Week High236.50
  • 52 Week High Date12/20/21
  • 52 Week Low15.53
  • 52 Week Low Date12/02/22

Key Stats

  • Market Cap1.352B
  • Shares Out78.50M
  • 10 Day Average Volume5.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change-87.96

KEY STATS

  • Open16.78
  • Day High17.79
  • Day Low16.74
  • Prev Close16.78
  • 52 Week High236.50
  • 52 Week High Date12/20/21
  • 52 Week Low15.53
  • 52 Week Low Date12/02/22
  • Market Cap1.352B
  • Shares Out78.50M
  • 10 Day Average Volume5.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.76
  • YTD % Change-87.96

RATIOS/PROFITABILITY

  • EPS (TTM)-17.25
  • P/E (TTM)-1.00
  • Fwd P/E (NTM)-7.47
  • EBITDA (TTM)-1.20B
  • ROE (TTM)-898.20%
  • Revenue (TTM)1.847B
  • Gross Margin (TTM)48.93%
  • Net Margin (TTM)-71.59%
  • Debt To Equity (MRQ)-77.40%

EVENTS

  • Earnings Date02/27/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Novavax Inc

Profile

MORE
Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its...
James Young Ph.D.
Independent Chairman of the Board
Stanley Erck
President, Chief Executive Officer, Director
Rick Crowley
Chief Operations Officer, Executive Vice President
James Kelly
Chief Financial Officer, Executive Vice President, Treasurer
Filip Dubovsky M.D.
Executive Vice President, Chief Medical Officer
Address
21 Firstfield Road
Gaithersburg, MD
20878
United States